[{"Assets_0_Q2_USD":647574000.0,"CommonStockSharesOutstanding_0_Q2_shares":42899318.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-39601000.0,"NetIncomeLoss_1_Q2_USD":-38701000.0,"NetIncomeLoss_2_Q2_USD":-79678000.0,"StockholdersEquity_0_Q2_USD":277089000.0,"Ticker":"TVTX","CIK":"1438533","name":"RETROPHIN, INC.","OfficialName":"Travere Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905907401.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]